121 related articles for article (PubMed ID: 21674844)
1. Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma.
Motta G; Cea M; Carbone F; Augusti V; Moran E; Patrone F; Nencioni A
J BUON; 2011; 16(1):9-15. PubMed ID: 21674844
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines.
Maloney DG
J Clin Oncol; 2005 Sep; 23(26):6421-8. PubMed ID: 16155029
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for HIV-associated non-Hodgkin's lymphoma.
Newsom-Davis T; Ahamed E; Bower M
Expert Opin Biol Ther; 2009 Oct; 9(10):1313-24. PubMed ID: 19645631
[TBL] [Abstract][Full Text] [Related]
4. Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.
Maloney DG; Press OW
Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):63-76. PubMed ID: 9830635
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives.
Motta G; Cea M; Moran E; Carbone F; Augusti V; Patrone F; Nencioni A
Clin Dev Immunol; 2010; 2010():428253. PubMed ID: 21437222
[TBL] [Abstract][Full Text] [Related]
6. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
8. Defining the role of immunotherapy and radioimmunotherapy in the treatment of low-grade lymphoma.
Winter JN
Curr Opin Hematol; 2007 Jul; 14(4):360-8. PubMed ID: 17534162
[TBL] [Abstract][Full Text] [Related]
9. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
Leonard JP; Gregory SA; Maloney DG; Vose JM; Younes A; Zelenetz AD
Clin Adv Hematol Oncol; 2008 Jun; 6(6):437-45. PubMed ID: 18567989
[TBL] [Abstract][Full Text] [Related]
11. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
Naparstek E
Curr Hematol Rep; 2005 Jul; 4(4):276-83. PubMed ID: 16009042
[TBL] [Abstract][Full Text] [Related]
12. Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation.
Tsai D; Moore H; Hardy C; Porter D; Loh E; Vaughn D; Luger S; Schuster S; Stadtmauer E
Bone Marrow Transplant; 1999 Sep; 24(5):521-6. PubMed ID: 10482937
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody.
Wiseman GA; White CA; Witzig TE; Gordon LI; Emmanouilides C; Raubitschek A; Janakiraman N; Gutheil J; Schilder RJ; Spies S; Silverman DH; Grillo-López AJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3281s-3286s. PubMed ID: 10541376
[TBL] [Abstract][Full Text] [Related]
15. A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections.
Seyfizadeh N; Seyfizadeh N; Hasenkamp J; Huerta-Yepez S
Crit Rev Oncol Hematol; 2016 Jan; 97():275-90. PubMed ID: 26443686
[TBL] [Abstract][Full Text] [Related]
16. Antibody-targeted therapy for low-grade lymphoma.
Vose JM
Semin Hematol; 1999 Oct; 36(4 Suppl 6):15-20. PubMed ID: 10530712
[TBL] [Abstract][Full Text] [Related]
17. Autologous hematopoietic stem cell transplant in first remission in non-Hodgkin's lymphoma.
Tomblyn M; Winter JN
Expert Rev Anticancer Ther; 2003 Jun; 3(3):281-94. PubMed ID: 12820773
[TBL] [Abstract][Full Text] [Related]
18. Novel and engineered anti-B-cell monoclonal antibodies for non-Hodgkin's lymphoma.
Martin P; Furman RR; Ruan J; Elstrom R; Barrientos J; Niesvizky R; Coleman M; Leonard JP
Semin Hematol; 2008 Apr; 45(2):126-32. PubMed ID: 18381108
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma.
Gregory SA; Hohloch K; Gisselbrecht C; Tobinai K; Dreyling M
Oncologist; 2009; 14 Suppl 2():4-16. PubMed ID: 19819920
[TBL] [Abstract][Full Text] [Related]
20. Treatment approaches and nursing considerations for non-Hodgkin's lymphoma.
Long J; Versea L
Semin Oncol Nurs; 2006 May; 22(2):97-106. PubMed ID: 16720232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
